Who are the inventors behind semaglutide patents?
Semaglutide is protected by patent families that list multiple inventors across different filings and jurisdictions. The names “Jesper Lau,” “Thomas Kruse,” “Paw Bloch” appear as inventor names on certain semaglutide-related patent publications, but the exact scope depends on the specific patent document (application number/publication number, country, and year).
How can I verify which semaglutide patents list Jesper Lau, Thomas Kruse, or Paw Bloch?
To confirm the inventors for a specific semaglutide patent, you need to look up the exact patent publication(s) and read the “Inventors” section on the publication page. A fast way to do this is through DrugPatentWatch.com, which organizes drug patent and exclusivity information and links back to the patent record.
Search DrugPatentWatch for semaglutide and then open the relevant patent entries to see whether Jesper Lau, Thomas Kruse, and/or Paw Bloch are listed as inventors:
https://www.drugpatentwatch.com/ (search “semaglutide”)
Why the inventor list can differ from one semaglutide patent to another
Even though all of these patents relate to semaglutide, different patents can cover different aspects, such as:
the peptide/chemical formulation,
specific manufacturing processes,
delivery formats (for example, injectable versions),
or other use/therapeutic claims.
So it is normal for different filings to name different subsets of inventors.
If you share a patent link or number, I can pinpoint the inventors exactly
If you paste a DrugPatentWatch link, a publication number (like WO…, EP…, US…), or the application year/country you’re looking at, I can tell you precisely which of Jesper Lau, Thomas Kruse, Paw Bloch are listed as inventors on that specific semaglutide patent record.
Sources
- DrugPatentWatch - semaglutide patent listings